European Movers: Wise (WISE LN) +10.3%, Kier (KIE LN) +4.1%, Renault (RNO FP) +1.6%, TotalEnergies (TTE FP) -0.4%, AstraZeneca (AZN LN) -1.0%, Carl Zeiss Meditec (AFX GY) -5.1%

• Wise (WISE LN) - Q3 Trading Update (GBP): Quarterly cross-border volume grew +25% YY. Underlying Income 424.4mln, +21% Y/Y. Outlook: "We now expect FY26 underlying PBT margin to be towards the top of this range, including costs related to Wise's dual listing". (Wise)
• Kier (KIE LN) - Trading Update (GBP): Order Book 11.6bln (prev. 11bln Y/Y). (Kier)
• Renault (RNO FP) – FY25 (Sales update): Vehicle Sales 2.37mln +3.2% Y/Y. EV vehicle sales 194k +767% Y/Y. Elsewhere, Renault said that it will help France develop a domestic drone industry after being approached by the Ministry of the Armed Forces, Bloomberg reports. The automaker will contribute its expertise as Europe responds to rising geopolitical tensions linked to US threats over Greenland. (Renault / Bloomberg)
• TotalEnergies (TTE FP) - Q4 Trading Update: Raises FY25 Production +4% (prev. +3%); European Refining Margin Marker USD 11.4/t (prev. USD 25.9/t Y/Y). Cuts FY25 Net Investment near USD 17bln (prev. USD 17-17.5bln). (Newswires)
• AstraZeneca (AZN LN) - Co. to complete its direct listing on NYSE; effective 30 Jan 2026, after market close. Ticker to remain AZN. (AstraZeneca)
• Carl Zeiss Meditec (AFX GY) downgraded to Neutral from Buy at Goldman Sachs

The mixed movements in European equities highlight sector-specific drivers: Wise's strong growth and positive outlook boost investor sentiment, while AstraZeneca's upcoming NYSE listing draws attention amidst a general market backdrop. However, TotalEnergies’ cut in net investment alongside a significant drop in refining margins suggests caution in the energy sector, while Carl Zeiss's downgrade indicates potential weakness in the healthcare equipment space. Overall, these movements reflect broader themes of sector resilience and caution in response to growth expectations and macroeconomic pressures.